Topical Metal Ion Sequestrant for Edema Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for localized edema, particularly those related to chronic venous insufficiency, are often ineffective and can be harmful if not properly monitored, as they may exacerbate the condition or cause additional circulation problems, and there is a lack of significant and lasting relief from edema symptoms.
Innovation Solution
A topical formulation containing a therapeutically effective amount of a metal ion sequestrant and an effective permeation-enhancing agent, such as methylsulfonylmethane, is applied to the affected area to sequester metal ions associated with edema and enhance penetration, potentially including an anti-inflammatory agent for inflammation-related edema.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If compression therapy is applied to treat localized edema, then edema reduction is achieved, but blood circulation may be excessively reduced or blocked causing harmful effects
Solution Approach 1:
The patent replaces the mechanical compression system with a chemical system. Instead of using physical pressure from compression bandages or devices, the invention uses topically applied metal ion sequestering agents that chemically bind to metal ions in the edematous tissue. This chemical mechanism achieves edema reduction without the mechanical forces that cause circulation blockage.
Solution Approach 2:
The patent introduces metal ion sequestering agents as intermediary substances that mediate between the skin surface and the edematous tissue. These agents penetrate the skin and bind to metal ions (such as iron) that contribute to oxidative stress and inflammation in the edematous tissue, providing a intermediate chemical action that avoids direct mechanical compression of blood vessels.
2Reliability
If pharmacological agents are used to treat localized edema, then some degree of improvement is achieved, but relief is minimal and short-lived
Solution Approach 1:
The patent changes the chemical parameters of the treatment by using specific metal ion sequestering agents with optimized chelating properties. Instead of using conventional anti-inflammatory drugs, the invention employs compounds that specifically bind to metal ions involved in oxidative stress pathways. This parameter change in the chemical mechanism leads to more effective and longer-lasting relief by addressing the root cause of edema through metal ion chelation rather than general anti-inflammatory action.
3Quantity of substance
If compression devices are tightly applied to reduce edema, then fluid accumulation is reduced, but the condition may be exacerbated or additional problems caused
Solution Approach 1:
The patent replaces the mechanical compression system with a chemical system. Instead of using physical pressure from compression bandages or devices, the invention uses topically applied metal ion sequestering agents that chemically bind to metal ions in the edematous tissue. This chemical mechanism achieves edema reduction without the mechanical forces that cause circulation blockage.
Solution Approach 2:
The patent enables the body's own physiological systems to resolve edema through the chemical action of metal ion sequestration. The sequestering agents bind to metal ions that are driving oxidative stress and inflammation, allowing the body's natural fluid regulation mechanisms to restore balance without external mechanical intervention. This self-service approach avoids the harmful effects of forced mechanical compression.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The formulation effectively reduces edema by sequestering metal ions that contribute to oxidative stress and inflammation, providing a more significant and lasting relief from edema symptoms compared to existing treatments, while minimizing risks associated with circulation.
Implementation Method 1
a therapeutically effective amount of a metal ion sequestrant... The sequestrant is capable of sequestering, e.g., chelating or otherwise sequestering metal ions
Implementation Method 2
an effective permeation-enhancing amount of a permeation enhancer... The permeation enhancer acts to increase the rate at which the metal ion sequestrant penetrates the body surface
Data Source
AI summary
Methods and formulations are provided for the treatment of localized edema, particularly localized edema resulting from chronic venous insufficiency. A metal ion sequestrant is topically administered to a subject afflicted with localized edema in combination with a permeation enhancer selected from methylsulfonylmethane and a combination of methylsulfonylmethane and dimethylsulfoxide. Topically administrable formulations for use in the aforementioned method are also provided.